JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2026. Vol. 71. № 3
DOI:10.33266/1024-6177-2026-71-3-53-59
T.Yu. Mushkarina1, E.G. Kuzmina1, L.Yu. Grivtsova1,2, S.A. Ivanov1,3, A.D. Kaprin3,4,5
The Effect of Gamma Radiation on Regulatory T Cells in Vitro
1 А.F. Tsyb Medical Radiological Research Centre – branch of the National Medical Research Radiological Centre, Obninsk, Russia
2 National Research Nuclear University MEPhI, Obninsk, Russia
3 Peoples Friendship University of Russia, Moscow, Russia
4 National Medical Research Radiological Centre, Obninsk, Russia
5 Р.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre, Moscow, Russia
Contact person: Т.Yu. Mushkarina, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To determine the sensitivity of T‑regulatory (Treg) to various doses of γ-radiation (2, 4, and 8 Gy) in vitro in primary lymphocyte cultures from healthy individuals and patients with non-Hodgkin’s lymphomas, to evaluate the effect of the time factor, and to compare their reactivity with other lymphocyte subsets.
Material and methods: Primary peripheral blood lymphocyte cultures from six healthy individuals and five patients with non-Hodgkin’s lymphomas were studied. The cells were irradiated at doses of 2, 4, and 8 Gy and cultured for up to 6 days. Identification of Treg cells (CD45+CD4+CD25+CD127low/-) and other lymphocyte subsets (T cells, T helper cells, T cytotoxic cells, B and NK cells) was performed by multicolored flow cytofluorometry. Statistical analysis of the data was performed using the Mann-Whitney U-test for pairwise comparison and the Kruskal-Wallis test for multiple comparison.
Results: There were no statistically significant changes in the percentage and absolute number of Treg cells in response to radiation at the studied doses in both groups (healthy individuals and patients with non-Hodgkin’s lymphoma), p>0.05. However, in the culture of lymphocytes in non-Hodgkin’s lymphomas, there was a tendency to increase their percentage at 8 Gy (1.3‑fold, p=0.06). The dynamics of Treg cells were dependent on the duration of cultivation. In healthy individuals, the absolute number of Treg cells decreased sharply by day 6 (11.5 times compared to day 1, p<0.05). In patients with non–Hodgkin’s lymphomas, the decrease occurred faster, reaching significant values by day 3 (2.2 times, p<0.05) and especially pronounced by day 5 (10‑fold, p<0.05), which may be due to the additional suppressive effect of tumor B cells. In a comparative analysis with other lymphocyte subsets in a group of healthy individuals, B cells were the most radiosensitive, while T-cytotoxic cells and NK cells showed the greatest resistance. Treg cells showed average sensitivity, being also more resistant than the general population of T helper cells. In the group of patients with non-Hodgkin’s lymphomas, NK cells, on the contrary, had the greatest radiosensitivity, which is potentially an unfavorable factor for antitumor immunity.
Conclusion: The in vitro study demonstrated intermediate resistance of Treg cells to gamma radiation at doses of 2, 4, and 8 Gy. Accurate assessment of the effects of ionizing radiation on Treg cells requires consideration of both dose characteristics and cellular kinetics over time following irradiation, as well as the presence of a pathological process.
Keywords: non-Hodgkin’s lymphoma, gamma radiation, regulatory T cells, lymphocyte subsets, in vitro tests
For citation: Mushkarina TYu, Kuzmina EG, Grivtsova LYu, Ivanov SA, Kaprin AD. The Effect of Gamma Radiation on Regulatory T Cells in Vitro. Medical Radiology and Radiation Safety. 2026;71(3):53–59. DOI:10.33266/1024-6177-2026-71-3-53-59
References
1.Hou P.F., Zhu L.J., Pan Y., Sun X.C., Pu J. The Relationship Between Regulatory T Cells and Radiation Therapy. Cancer Radiother. 2020;24;1:81-84. Doi: 10.1016/j.canrad.2019.07.160. PMID: 32046914.
2.Guo T., Zou L., Ni J., Zhou Y., Ye L., Yang X., Zhu Z. Regulatory T Cells: an Emerging Player in Radiation-Induced Lung Injury. Front Immunol. 2020;11:1769. Doi: 10.3389/fimmu.2020.01769. PMID: 32849634.
3.Beauford S.S., Kumari A., Garnett-Benson C. Ionizing Radiation Modulates the Phenotype and Function of Human CD4+ Induced Regulatory T Cells. BMC Immunol. 2020;21;1:18. Doi: 10.1186/s12865-020-00349-w. PMID: 32299365.
4.Qu Y., Zhang B., Liu S., Zhang A., Wu T., Zhao Y. 2-Gy Whole-Body Irradiation Significantly Alters the Balance of CD4+CD25-T Effector Cells and CD4+CD25+Foxp3+T Regulatory Cells in Mice. Cell Mol Immunol. 2010;7;6:419-27. Doi: 10.1038/cmi.2010.45. PMID: 20871628.
5.Qu Y., Jin S., Zhang A., Zhang B., Shi X., Wang J., Zhao Y. Gamma-Ray Resistance of Regulatory CD4+CD25+Foxp3+ T Cells in Mice. Radiat Res. 2010;173;2:148-57. Doi: 10.1667/RR0978.1. PMID: 20095846.
6.Billiard F., Buard V., Benderitter M., Linard C. Abdominal γ-Radiation Induces an Accumulation of Function-Impaired Regulatory T Cells in the Small Intestine. Int J Radiat Oncol Biol Phys. 2011;80;3:869-76. Doi: 10.1016/j.ijrobp.2010.12.041. PMID: 21345609.
7.Kachikwu E.L., Iwamoto K.S., Liao Y.P., DeMarco J.J., Agazaryan N., Economou J.S., McBride W.H., Schaue D. Radiation Enhances Regulatory T Cell Representation. Int J Radiat Oncol Biol Phys. 2011;81;4:1128-35. Doi: 10.1016/j.ijrobp.2010.09.034. PMID: 21093169.
8.Liu R., Xiong S., Zhang L., Chu Y. Enhancement of Antitumor Immunity by Low-Dose Total Body Irradiationis Associated with Selectively Decreasing the Proportion and Number of T Regulatory Cells. Cell Mol Immunol. 2010;7;2:157-62. Doi: 10.1038/cmi.2009.117. PMID: 20140010.
9.Wei S., Egenti M.U., Teitz-Tennenbaum S., Zou W., Chang A.E. Effects of Tumor Irradiation on Host T-Regulatory Cells and Systemic Immunity in the Context of Adoptive T-Cell Therapy in Mice. J Immunother. 2013;36;2:124-32. Doi: 10.1097/CJI.0b013e31828298e6. PMID: 23377667.
10.Battaglia A., Buzzonetti A., Martinelli E., Fanelli M., Petrillo M., Ferrandina G., Scambia G., Fattorossi A. Selective Changes in the Immune Profile of Tumor-Draining Lymph Nodes after Different Neoadjuvant Chemoradiation Regimens for Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys. 2010;76;5:1546-53. Doi: 10.1016/j.ijrobp.2009.10.014. PMID: 20338481.
11.Wang M., Gou X., Wang L. Protein Kinase B Promotes Radiation-Induced Regulatory T Cell Survival in Bladder Carcinoma. Scand J Immunol. 2012;76;1:70-4. Doi: 10.1111/j.1365-3083.2012.02707.x. PMID: 22486221.
12.Zhang T., Yu H., Ni C., Zhang T., Liu L., Lv Q., Zhang Z., Wang Z., Wu D., Wu P., Chen G., Wang L., Wei Q., Huang J., Wang X. Hypofractionated Stereotactic Radiation Therapy Activates the Peripheral Immune Response in Operable Stage I Non-Small-Cell Lung Cancer. Sci Rep. 2017;7;1:4866. Doi: 10.1038/s41598-017-04978-x. PMID: 28687760.
13.Кузьмина Е.Г., Мушкарина Т.Ю., Константинова Т.В. Регуляторные T-лимфоциты (Treg) при лимфопролиферативных заболеваниях // Современная онкология. 2016. Т.18. №.5. C. 41-42. [Kuz’mina Ye.G., Mushkarina T.Yu., Konstantinova T.V. Regulatory T-lymphocytes (Treg) in Lymphoproliferative Diseases. Sovremennaya Onkologiya = Modern Oncology. 2016;18;5:41-42 (In Russ.)].
14.Maharaj K., Uriepero A., Sahakian E., Pinilla-Ibarz J. Regulatory T Cells (Tregs) in Lymphoid Malignancies and the Impact of Novel Therapies. Front Immunol. 2022;13:943354. Doi: 10.3389/fimmu.2022.943354. PMID: 35979372.
15.Heylmann D., Rödel F., Kindler T., Kaina B. Radiation Sensitivity of Human and Murine Peripheral Blood Lymphocytes, Stem and Progenitor Cells. Biochim Biophys Acta. 2014;1846;1:121-9. Doi: 10.1016/j.bbcan.2014.04.009. PMID: 24797212.
16.Paganetti H. A Review on Lymphocyte Radiosensitivity and its Impact on Radiotherapy. Front Oncol. 2023;13:1201500. Doi: 10.3389/fonc.2023.1201500. PMID: 37601664.
17.Heylmann D., Ponath V., Kindler T., Kaina B. Comparison of DNA Repair and Radiosensitivity of Different Blood Cell Populations. Sci Rep. 2021;11;1:2478. Doi: 10.1038/s41598-021-81058-1. PMID: 33510180.
18.Formenti S.C., Demaria S. Combining Radiotherapy and Cancer Immunotherapy: a Paradigm Shift. J Natl Cancer Inst. 2013;105;4:256-65. Doi: 10.1093/jnci/djs629. PMID: 23291374.
19.Li C.G., He M.R., Wu F.L., Li Y.J., Sun A.M. Akt promotes irradiation-induced regulatory T-cell survival in hepatocellular carcinoma. Am J Med Sci. 2013;346(2):123-7. Doi: 10.1097/MAJ.0b013e31826ceed0. PMID: 23255243.
20.Winzler C., Fantinato M., Giordan M., Calore E., Basso G., Messina C. CD4(+) T Regulatory Cells are More Resistant to DNA Damage Compared to CD4(+) T Effector Cells as Revealed by Flow Cytometric Analysis. Cytometry A. 2011;79;11:903-11. Doi: 10.1002/cyto.a.21132. PMID: 22015731.
21.McFarland H.I., Puig M., Grajkowska L.T., Tsuji K., Lee J.P., Mason K.P., Verthelyi D., Rosenberg A.S. Regulatory T Cells in γ Irradiation-Induced Immune Suppression. PLoS One. 2012;7;6:e39092. Doi: 10.1371/journal.pone.0039092. PMID: 22723935.
22.Komatsu N., Hori S. Full Restoration of Peripheral Foxp3+ Regulatory T Cell Pool by Radioresistant Host Cells in Scurfy Bone Marrow Chimeras. Proc Natl Acad Sci USA. 2007;104;21:8959-64. Doi: 10.1073/pnas.0702004104. PMID: 17494743.
23.Balogh A., Persa E., Bogdándi E.N., Benedek A., Hegyesi H., Sáfrány G., Lumniczky K. The Effect of Ionizing Radiation on the Homeostasis and Functional Integrity of Murine Splenic Regulatory T cells. Inflamm Res. 2013;62;2:201-12. Doi: 10.1007/s00011-012-0567-y. PMID: 23080082.
24.Mougiakakos D., Johansson C.C., Kiessling R. Naturally Occurring Regulatory T Cells Show Reduced Sensitivity Toward Oxidative Stress-Induced Cell Death. Blood. 2009;113;15:3542-5. Doi: 10.1182/blood-2008-09-181040. PMID: 19050306.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.02.2026. Accepted for publication: 25.03.2026.